Scholarlink

Purpose of review <p>Recent advancements in artificial intelligence (AI) applied to coronary computed tomography angiography (CCTA) may refine personalized care by enhancing visualization of atherosclerosis, improving cardiovascular risk stratification and treatment guidance. The present review focuses on AI-guided innovations in CCTA analysis to evaluate atherosclerotic cardiovascular disease (ASCVD), its prognostic utility, and future directions.</p> Recent findings <p>AI-guided CCTA-analysis facilitates automated, reproducible, and scalable quantification of atherosclerosis. A growing body of evidence supports the diagnostic performance of AI-guided plaque quantification on CCTA. These advances support a shift toward more objective and individualized patient care beyond traditional, population-based approaches.</p> Summary <p>As CCTA continues to evolve as an established, first-line diagnostic test to assess ASCVD, a growing body of evidence also supports the diagnostic accuracy and prognostic value of AI-guided CCTA.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Innovations In Artificial Intelligence-Guided Atherosclerosis Cardiovascular Imaging: From Detection to Prognosis

  • 期刊论文

  • 发表日期：

    2026年3月27日

查看全文
  • Sophie H.M. Cramer,
  • Ibrahim Danad,
  • Paul Knaapen,
  • Nick S. Nurmohamed,
  • Andrew D. Choi

摘要

Purpose of review

Recent advancements in artificial intelligence (AI) applied to coronary computed tomography angiography (CCTA) may refine personalized care by enhancing visualization of atherosclerosis, improving cardiovascular risk stratification and treatment guidance. The present review focuses on AI-guided innovations in CCTA analysis to evaluate atherosclerotic cardiovascular disease (ASCVD), its prognostic utility, and future directions.

Recent findings

AI-guided CCTA-analysis facilitates automated, reproducible, and scalable quantification of atherosclerosis. A growing body of evidence supports the diagnostic performance of AI-guided plaque quantification on CCTA. These advances support a shift toward more objective and individualized patient care beyond traditional, population-based approaches.

Summary

As CCTA continues to evolve as an established, first-line diagnostic test to assess ASCVD, a growing body of evidence also supports the diagnostic accuracy and prognostic value of AI-guided CCTA.